(AGENPARL) – gio 27 aprile 2023 Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy…
Browsing: pre-treatment
(AGENPARL) – mer 02 novembre 2022 9.30 PM CET / 2-Nov-2022 / Hansa Biopharma AB (STO:HNSA) Hansa Biopharma and partner…